PMCPA Case
| Case | AUTH/3174/3/19 |
| Parties | Anonymous Employees v Otsuka Europe |
| Applicable Code year | 2016 |
| Complaint received | 20 March 2019 |
| Case completed | 16 October 2019 |
| Key activities | 2018 ERA-EDTA Congress symposium (Copenhagen) and internal management update meeting (18 March 2019) |
| Product referenced | Tolvaptan (Jinarc) |
| Breach clauses | Clause 2; Clause 9.1; Clause 12.1 |
| Sanctions | Undertaking received; Advertisement |
| Notable “no breach” point | Allegation about training staff to give “appropriate answers” for the audit: no breach (outside scope of the Code) |
| Source | https://www.pmcpa.org.uk/cases/completed-cases/auth3174319-anonymous-employees-v-otsuka-europe |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.